NCT05291507View on ClinicalTrials.gov

Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

August 2, 2022

Primary Completion Date

August 1, 2025

Study Completion Date

August 1, 2027

Conditions
Breast Cancer
Interventions
DEVICE

Muse MRgFUS System

The intended use of the device is to thermally ablate breast tissue under magnetic resonance image guidance. The thermal ablation is performed non-invasively using extracorporeal focused ultrasound.

Trial Locations (1)

84112

RECRUITING

Huntsman Cancer Institute at University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER